Anthony Hunt - 11 Nov 2022 Form 4 Insider Report for REPLIGEN CORP (RGEN)

Role
Chief Executive Officer, Director
Signature
/s/ Kimberly Brown (Attorney in Fact)
Issuer symbol
RGEN
Transactions as of
11 Nov 2022
Net transactions value
-$4,153,250
Form type
4
Filing time
14 Nov 2022, 16:43:46 UTC
Previous filing
09 Sep 2022
Next filing
28 Feb 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RGEN Common Stock Options Exercise $846,750 +25,000 +14% $33.87* 203,265 11 Nov 2022 Direct
transaction RGEN Common Stock Sale $5,000,000 -25,000 -12% $200.00 178,265 11 Nov 2022 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction RGEN Stock Option (Right to Buy) Options Exercise $0 +25,000 +270% $0.000000 34,246 11 Nov 2022 Common Stock 25,000 $33.87 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Sale of common stock was effected pursuant to a 10(b)5-1 trading plan adopted on December 14, 2021.
F2 This option is fully vested and exercisable.